SOADOR
USNA icon

State of Alaska Department of Revenue’s Usana Health Sciences USNA Stock Holding History

State of Alaska Department of Revenue’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Hold
6,666
– – ﹤0.01% 1704
2026
Q1 		$115K Hold
6,666
– – ﹤0.01% 1740
2025
Q4 		$130K Buy
6,666
+525
+9% +$10.9K ﹤0.01% 1738
2025
Q3 		$168K Sell
6,141
-282
-4% -$8.68K ﹤0.01% 1614
2025
Q2 		$195K Buy
6,423
+297
+5% +$8.43K ﹤0.01% 1560
2025
Q1 		$165K Sell
6,126
-143
-2% -$4.53K ﹤0.01% 1568
2024
Q4 		$224K Sell
6,269
-37
-0.6% -$1.38K ﹤0.01% 1557
2024
Q3 		$239K Sell
6,306
-182
-3% -$7.48K ﹤0.01% 1569
2024
Q2 		$293K Sell
6,488
-272
-4% -$12.5K ﹤0.01% 1534
2024
Q1 		$327K Sell
6,760
-66
-1% -$3.23K ﹤0.01% 1511
2023
Q4 		$365K Sell
6,826
-145
-2% -$7.33K ﹤0.01% 1490
2023
Q3 		$408K Sell
6,971
-394
-5% -$24.6K 0.01% 1419
2023
Q2 		$464K Sell
7,365
-261
-3% -$16.6K 0.01% 1404
2023
Q1 		$479K Sell
7,626
-130
-2% -$7.76K 0.01% 1386
2022
Q4 		$412K Buy
7,756
+47
+0.6% +$2.55K 0.01% 1435
2022
Q3 		$432K Sell
7,709
-1,000
-11% -$66.1K 0.01% 1371
2022
Q2 		$630K Buy
8,709
+585
+7% +$43.6K 0.01% 1241
2022
Q1 		$645K Sell
8,124
-145
-2% -$13.1K 0.01% 1270
2021
Q4 		$836K Sell
8,269
-490
-6% -$48.9K 0.01% 1188
2021
Q3 		$807K Buy
8,759
+782
+10% +$75.2K 0.01% 1209
2021
Q2 		$817K Sell
7,977
-73
-0.9% -$7.33K 0.01% 1190
2021
Q1 		$785K Sell
8,050
-1,280
-14% -$116K 0.01% 1201
2020
Q4 		$719K Sell
9,330
-1,883
-17% -$146K 0.01% 1152
2020
Q3 		$825K Sell
11,213
-280
-2% -$22.5K 0.01% 976
2020
Q2 		$843K Sell
11,493
-150
-1% -$11.8K 0.01% 967
2020
Q1 		$672K Buy
11,643
+2,165
+23% +$151K 0.01% 958
2019
Q4 		$744K Sell
9,478
-439
-4% -$32.3K 0.01% 1083
2019
Q3 		$678K Buy
9,917
+5,392
+119% +$362K 0.01% 1103
2019
Q2 		$359K Buy
+4,525
New +$359K 0.01% 1227

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

State of Alaska Department of Revenue's USNA Position: Q2 2026 in Review

State of Alaska Department of Revenue held its Usana Health Sciences (USNA) position steady in Q2 2026 at 6,666 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #1704.

State of Alaska Department of Revenue first reported a position in USNA in Q2 2019 and has held it in 29 quarters since. The position peaked at $843K in Q2 2020. 71 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • State of Alaska Department of Revenue held 6,666 shares of Usana Health Sciences worth $142K as of Q2 2026.
  • State of Alaska Department of Revenue left its Usana Health Sciences share count unchanged in Q2 2026.
  • Usana Health Sciences made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1704 holding.
  • State of Alaska Department of Revenue first reported a position in Usana Health Sciences in Q2 2019 and has held it in 29 quarters since.
  • State of Alaska Department of Revenue's Usana Health Sciences position peaked at $843K in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.